Difference between revisions of "ERCC1"
(Created page with "==Annotation== ===Name=== ERCC1 ===Alias=== NA ===Disease=== Disease: gastric cancer [http://www.ncbi.nlm.nih.gov/pubmed/25260808 (PMID:25260808)] Dysfunction type: express...") |
|||
| Line 1: | Line 1: | ||
==Annotation== | ==Annotation== | ||
===Name=== | ===Name=== | ||
| − | + | AC138128.1 | |
| + | |||
===Alias=== | ===Alias=== | ||
| Line 19: | Line 20: | ||
Biological Process: pathogenic process | Biological Process: pathogenic process | ||
| − | Description: | + | Description: biomarker |
Revision as of 02:21, 5 November 2018
Contents
Annotation
Name
AC138128.1
Alias
NA
Disease
Disease: gastric cancer (PMID:25260808)
Dysfunction type: expression
Description: The expression level of AC138128.1 in GC was significantly decreased compared to that in NAT. Levels of AC138128.1 in the GC cell lines, AGS BGC-823, HG27, and SGC-7901 were lower than those in the human normal gastric epithelial cell line GES-1. lncRNA AC138128.1 might be a novel biomarker for predicting GC.
Function
Function Mechanism: NA (PMID:25260808)
Biological Process: pathogenic process
Description: biomarker
